<bill session="111" type="s" number="369" updated="2009-03-07T14:17:27-05:00">
	<status><introduced date="1233637200" datetime="2009-02-03"/></status>

	<introduced date="1233637200" datetime="2009-02-03"/>
	<titles>
		<title type="short" as="introduced">Preserve Access to Affordable Generics Act</title>
		<title type="official" as="introduced">A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.</title>
	</titles>
	<sponsor id="300061"/>
	<cosponsors>
		<cosponsor id="400050" joined="2009-02-03"/>
		<cosponsor id="300048" joined="2009-02-03"/>
		<cosponsor id="300042" joined="2009-02-03"/>
		<cosponsor id="300038" joined="2009-02-03"/>
	</cosponsors>
	<actions>
		<action date="1233637200" datetime="2009-02-03"><text>Sponsor introductory remarks on measure. (CR S1433)</text></action>
		<action date="1233637200" datetime="2009-02-03"><text>Read twice and referred to the Committee on the Judiciary.</text><reference label="text of measure as introduced" ref="CR S1433-1434"/></action>
	</actions>
	<committees>
		<committee name="Senate Judiciary" subcommittee="" activity="Referral, In Committee" />
	</committees>
	<relatedbills>

	</relatedbills>
	<subjects>
		<term name="Commerce"/>
		<term name="Administrative law and regulatory procedures"/>
		<term name="Competition and antitrust"/>
		<term name="Contracts and agency"/>
		<term name="Federal Trade Commission (FTC)"/>
		<term name="Intellectual property"/>
		<term name="Marketing and advertising"/>
		<term name="Prescription drugs"/>
	</subjects>
	<amendments>

	</amendments>
	<summary>
	
	</summary>
</bill>
